Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun An
experimental drug for the treatment ofmultiple sclerosis .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word dirucotide.
Examples
-
I got an email today from a friend, asking if I had ever heard of a MS drug called dirucotide, and I of course said no.
Baltiblogs 2009
-
Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that dirucotide will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release.
Medindia Health News 2010
-
"During the third quarter, the Company made significant progress towards completing its termination of the dirucotide clinical trials, and in reducing expenditures," said Kevin Giese, President and CEO of BioMS Medical.
Medindia Health News 2009
-
BioMS Medical's lead technology, dirucotide, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for Secondary Progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States.
-
BioMS Medical's lead technology, dirucotide, is for the treatment of multiple sclerosis.
Medindia Health News 2009
-
In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to dirucotide in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales.
-
The study is being conducted at 47 sites across Canada and nine countries in Europe and includes 611 patients being administered either dirucotide or placebo intravenously every six months for a period of two years.
-
MAESTRO-01 is a multi-center, double-blind, placebo-controlled trial designed to evaluate the safety and efficacy of dirucotide in patients with secondary progressive MS.
-
Select USAN / INN Assignments afimoxifene bevirimat dimeglumine canfosfamide hydrochloride eprodisate disodium dirucotide acetate migalastat hydrochloride entinostat pegloticase ingenol mebutate tigapotide triflutate elesclomol tramiprosate ezatiostat hydrochloride varlitinib otelixizumab New York San Francisco Munich Charlotte Tokyo (coming soon)
-
EDMONTON, April 21 / PRNewswire-FirstCall / - BioMS Medical Corp., a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) for the Company's pivotal phase III MAESTRO-01 Canadian / European trial of dirucotide in patients with secondary progressive MS has completed a safety analysis and recommended that the trial continue as per the protocol.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.